Virtus ETF Advisers’s bluebird bio BLUE Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2024
Q2 | – | Sell |
-5,773
| Closed | -$148K | – | 454 |
|
|
2024
Q1 | $148K | Buy |
5,773
+831
| +17% | +$21.3K | 0.08% | 330 |
|
|
2023
Q4 | $136K | Buy |
4,942
+1,001
| +25% | +$61K | 0.09% | 316 |
|
|
2023
Q3 | $240K | Sell |
3,941
-510
| -11% | -$35.8K | 0.15% | 229 |
|
|
2023
Q2 | $293K | Buy |
4,451
+2,611
| +142% | +$191K | 0.17% | 213 |
|
|
2023
Q1 | $117K | Buy |
1,840
+33
| +2% | +$3.77K | 0.06% | 327 |
|
|
2022
Q4 | $250K | Buy |
+1,807
| New | +$255K | 0.13% | 303 |
|
|
2022
Q2 | – | Sell |
-2,030
| Closed | -$197K | – | 445 |
|
|
2022
Q1 | $197K | Hold |
2,030
| – | – | 0.09% | 199 |
|
|
2021
Q4 | $406K | Buy |
2,030
+977
| +93% | +$231K | 0.15% | 143 |
|
|
2021
Q3 | $261K | Sell |
1,053
-97
| -8% | -$27.7K | 0.11% | 213 |
|
|
2021
Q2 | $476K | Buy |
1,150
+630
| +121% | +$250K | 0.2% | 165 |
|
|
2021
Q1 | $203K | Buy |
520
+9
| +2% | +$4.43K | 0.09% | 328 |
|
|
2020
Q4 | $287K | Buy |
511
+140
| +38% | +$88.7K | 0.12% | 231 |
|
|
2020
Q3 | $260K | Sell |
371
-52
| -12% | -$40.6K | 0.14% | 253 |
|
|
2020
Q2 | $334K | Buy |
423
+114
| +37% | +$86K | 0.16% | 281 |
|
|
2020
Q1 | $184K | Sell |
309
-46
| -13% | -$44.8K | 0.08% | 280 |
|
|
2019
Q4 | $403K | Buy |
355
+189
| +114% | +$205K | 0.07% | 251 |
|
|
2019
Q3 | $198K | Sell |
166
-10
| -6% | -$15.3K | 0.04% | 254 |
|
|
2019
Q2 | $289K | Sell |
176
-27
| -13% | -$46.7K | 0.06% | 232 |
|
|
2019
Q1 | $415K | Sell |
203
-24
| -11% | -$42.3K | 0.88% | 35 |
|
|
2018
Q4 | $291K | Buy |
227
+41
| +22% | +$62.9K | 0.05% | 118 |
|
|
2018
Q3 | $352K | Sell |
186
-132
| -42% | -$273K | 0.04% | 177 |
|
|
2018
Q2 | $647K | Sell |
318
-3
| -0.9% | -$6.84K | 0.57% | 123 |
|
|
2018
Q1 | $709K | Buy |
321
+171
| +114% | +$435K | 0.62% | 92 |
|
|
2017
Q4 | $345K | Sell |
150
-77
| -34% | -$156K | 0.43% | 99 |
|
|
2017
Q3 | $404K | Buy |
227
+20
| +10% | +$27.9K | 0.05% | 109 |
|
|
2017
Q2 | $281K | Sell |
207
-106
| -34% | -$128K | 0.04% | 135 |
|
|
2017
Q1 | $369K | Buy |
313
+30
| +11% | +$30.6K | 0.07% | 120 |
|
|
2016
Q4 | $226K | Sell |
283
-193
| -41% | -$153K | 0.07% | 164 |
|
|
2016
Q3 | $418K | Hold |
476
| – | – | 0.2% | 78 |
|
|
2016
Q2 | $267K | Buy |
476
+148
| +45% | +$83.8K | 0.2% | 72 |
|
|
2016
Q1 | $181K | Buy |
+328
| New | +$201K | 0.25% | 98 |
|
Other funds holding BLUE
PAI
Virtus ETF Advisers's BLUE Position: Q2 2024 in Review
Virtus ETF Advisers sold out of bluebird bio (BLUE) in Q2 2024, closing a stake of 5,773 shares — an estimated $148K sold.
Virtus ETF Advisers first reported a position in BLUE in Q1 2016 and held it in 31 quarters. The position peaked at $709K in Q1 2018. 150 funds tracked by Wall St. Rank hold BLUE as of Q2 2024.
- Virtus ETF Advisers reported no remaining bluebird bio position as of Q2 2024 after selling out during the quarter.
- Virtus ETF Advisers sold 5,773 bluebird bio shares in Q2 2024, an estimated $148K.
- Virtus ETF Advisers first reported a position in bluebird bio in Q1 2016 and held it in 31 quarters.
- Virtus ETF Advisers's bluebird bio position peaked at $709K in Q1 2018.
- 150 funds tracked by Wall St. Rank held bluebird bio as of Q2 2024.
Based on Virtus ETF Advisers's 13F filing for Q2 2024, filed 14 Aug 2024.